Guimalan, Miguela D.
HRN: 29-21-35 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/24/2026
07/01/2026
IV
1.5g
Q8
Infected Wound, Left Toe
Checking Initial Appropriateness
06/24/2026
MUPIROCIN 2%, 15G (TUBE)
06/24/2026
07/01/2026
TOPICAL
To Affected Area
BID
Pressure Ulcer
Checking Initial Appropriateness
06/24/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/24/2026
07/01/2026
IV
600mg
Q8H
DM FOOT
Checking Initial Appropriateness
06/28/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/28/2026
07/05/2026
IV
2.25
Q6
DM Foot
Checking Initial Appropriateness
07/05/2026
MUPIROCIN 2%, 15G (TUBE)
07/05/2026
07/11/2026
TOPICAL
2%
TID
Ulcer
Checking Initial Appropriateness
07/11/2026
MUPIROCIN 2%, 15G (TUBE)
07/11/2026
07/18/2026
TOPICAL
Apply On Affected Area
TID
Pressure Ulcer
Checking Initial Appropriateness